UNIVERSITY OF MIAMI
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1925-01-01
- Employees
- 10K
- Market Cap
- -
Mindfulness Training for Senior Leaders
Not Applicable
Terminated
- Conditions
- Interventions
- First Posted Date
- 2020-10-06
- Last Posted Date
- 2024-06-28
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 91
- Registration Number
- NCT04576832
- Locations
- 🇺🇸
University of Miami, Coral Gables, Florida, United States
SmartManage Stress Management for HIV+ Cancer Survivors
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2020-09-10
- Last Posted Date
- 2024-05-17
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 50
- Registration Number
- NCT04544917
- Locations
- 🇺🇸
University of Miami, Miami, Florida, United States
My Health Day by Day (Mi Salud Dia a Dia)
Completed
- Conditions
- First Posted Date
- 2020-09-10
- Last Posted Date
- 2024-08-01
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 200
- Registration Number
- NCT04545021
- Locations
- 🇺🇸
University of Miami, Miami, Florida, United States
Sensors Prediction Study
Recruiting
- Conditions
- First Posted Date
- 2020-09-09
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 8300
- Registration Number
- NCT04541992
- Locations
- 🇺🇸
Womack Army Medical Center, Fort Bragg, North Carolina, United States
Liposomal Bupivacaine in Adductor Canal Blocks (ACB)
Phase 4
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2020-09-07
- Last Posted Date
- 2021-12-22
- Lead Sponsor
- University of Miami
- Registration Number
- NCT04539730
Testopel ® vs. Generic Testosterone Pellets.
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-08-21
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 75
- Registration Number
- NCT04523480
- Locations
- 🇺🇸
University of Miami, Department of Urology, Miami, Florida, United States
Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated Delirium
Phase 4
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2020-08-14
- Last Posted Date
- 2023-03-31
- Lead Sponsor
- University of Miami
- Registration Number
- NCT04513314
Cross Sectional CFAR HIV/COVID-19 Study
Completed
- Conditions
- First Posted Date
- 2020-08-14
- Last Posted Date
- 2021-03-23
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 64
- Registration Number
- NCT04514016
- Locations
- 🇺🇸
Batchelor's Children's Research Institute, Miami, Florida, United States
PRP for Treatment of Peyronie's Disease
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2020-08-13
- Last Posted Date
- 2024-11-28
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 80
- Registration Number
- NCT04512287
- Locations
- 🇺🇸
University of Miami, Miami, Florida, United States
Optical Coherence Tomography Guided C&D
Not Applicable
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2020-08-12
- Last Posted Date
- 2024-02-20
- Lead Sponsor
- University of Miami
- Registration Number
- NCT04510727
- Locations
- 🇺🇸
Maria V Muniz, Miami, Florida, United States
© Copyright 2024. All Rights Reserved by MedPath